A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Dose-Response and Safety of STA-2 in Patients With Chronic Stable Angina.
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2014
At a glance
- Drugs Polyphenon E (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Sponsors Sinphar Pharmaceutical
- 26 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2011 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 10 Aug 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.